Citigroup Inc Ironwood Pharmaceuticals Inc Transaction History

Citigroup Inc

$190 Billion
Q1 2025

A detailed history of Citigroup Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 110,166 shares of IRWD stock, worth $79,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares

110,166

Previous 295,961 62.78%

Holding current value

$79,319

Previous $1.31 Million 87.72%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$1.41 - $4.58 $261,970 - $850,941	-185,795 Reduced 62.78%	110,166 $161,000
Q4 2024 Feb 12, 2025	BUY	$3.34 - $5.04 $366,691 - $553,331	109,788 Added 58.97%	295,961 $1.31 Million
Q3 2024 Nov 12, 2024	BUY	$3.93 - $7.04 $5,914 - $10,595	1,505 Added 0.81%	186,173 $765,000
Q2 2024 Aug 12, 2024	SELL	$5.58 - $8.61 $4.26 Million - $6.57 Million	-763,042 Reduced 80.51%	184,668 $1.2 Million
Q1 2024 May 10, 2024	BUY	$8.32 - $15.45 $4.87 Million - $9.05 Million	585,710 Added 161.8%	947,710 $8.25 Million
Q4 2023 Feb 09, 2024	SELL	$8.79 - $11.51 $595,856 - $780,239	-67,788 Reduced 15.77%	362,000 $4.14 Million
Q3 2023 Nov 09, 2023	BUY	$8.25 - $11.35 $67,130 - $92,354	8,137 Added 1.93%	429,788 $4.14 Million
Q2 2023 Aug 10, 2023	SELL	$10.1 - $11.6 $1.63 Million - $1.87 Million	-161,276 Reduced 27.67%	421,651 $4.49 Million
Q1 2023 May 11, 2023	BUY	$10.37 - $12.56 $949,000 - $1.15 Million	91,514 Added 18.62%	582,927 $6.13 Million
Q4 2022 Feb 09, 2023	SELL	$9.9 - $12.43 $1.63 Million - $2.05 Million	-164,581 Reduced 25.09%	491,413 $6.09 Million
Q3 2022 Nov 10, 2022	BUY	$10.14 - $12.38 $2.55 Million - $3.11 Million	251,371 Added 62.12%	655,994 $6.8 Million
Q2 2022 Aug 10, 2022	BUY	$11.05 - $12.72 $3.43 Million - $3.95 Million	310,252 Added 328.76%	404,623 $4.67 Million
Q1 2022 May 12, 2022	SELL	$10.61 - $12.88 $3.42 Million - $4.15 Million	-322,112 Reduced 77.34%	94,371 $1.19 Million
Q4 2021 Feb 10, 2022	BUY	$10.86 - $13.95 $959,328 - $1.23 Million	88,336 Added 26.92%	416,483 $4.86 Million
Q3 2021 Nov 10, 2021	BUY	$11.92 - $13.92 $3.91 Million - $4.57 Million	328,147 New	328,147 $4.29 Million

Others Institutions Holding IRWD

# of Institutions

222

Shares Held

166M

Call Options Held

11.2M

Put Options Held

6.9K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $110M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account